Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Arkwright

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
The Journal of Allergy and Clinical Immunology|October 11, 2008
Automatic epinephrine device use in children with food allergiesPeter D Arkwright
The Journal of Allergy and Clinical Immunology|February 11, 2009
Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticariaPeter D Arkwright
Current Opinion in Infectious Diseases|May 2, 2008
Recently identified factors predisposing children to infectious diseasesPeter D Arkwright, Mario Abinun
Frontiers in Pharmacology|February 6, 2023
Regional risk of <i>tuberculosis</i> and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic reviewNina Jahnich, Peter D Arkwright
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 8, 2020
Fennel as a cause of immediate hypersensitivity to toothpasteDespoina Denaxa, Peter D Arkwright
The Journal of Allergy and Clinical Immunology. in Practice|February 8, 2021
Introducing a New Epoch in Inborn Errors of ImmunityPeter D Arkwright, Jolan E Walter
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2022
Impact of a Decade of Research Into Atopic DermatitisPeter D Arkwright, Jennifer J Koplin
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2022
Striving for Evidence-Based Management of Food AllergiesPeter D Arkwright, Jennifer J Koplin
Annals of the New York Academy of Sciences|December 2, 2011
Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st centuryPeter D Arkwright, Andrew R Gennery
The Journal of Dermatological Treatment|March 9, 2012
Factors determining the effectiveness of oral ciclosporin in the treatment of severe childhood atopic dermatitisDavid R Beaumont, Peter D Arkwright
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
The Journal of Allergy and Clinical Immunology|October 11, 2008
Automatic epinephrine device use in children with food allergiesPeter D Arkwright
The Journal of Allergy and Clinical Immunology|February 11, 2009
Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticariaPeter D Arkwright
Current Opinion in Infectious Diseases|May 2, 2008
Recently identified factors predisposing children to infectious diseasesPeter D Arkwright, Mario Abinun
Frontiers in Pharmacology|February 6, 2023
Regional risk of <i>tuberculosis</i> and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic reviewNina Jahnich, Peter D Arkwright
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 8, 2020
Fennel as a cause of immediate hypersensitivity to toothpasteDespoina Denaxa, Peter D Arkwright
The Journal of Allergy and Clinical Immunology. in Practice|February 8, 2021
Introducing a New Epoch in Inborn Errors of ImmunityPeter D Arkwright, Jolan E Walter
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2022
Impact of a Decade of Research Into Atopic DermatitisPeter D Arkwright, Jennifer J Koplin
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2022
Striving for Evidence-Based Management of Food AllergiesPeter D Arkwright, Jennifer J Koplin
Annals of the New York Academy of Sciences|December 2, 2011
Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st centuryPeter D Arkwright, Andrew R Gennery
The Journal of Dermatological Treatment|March 9, 2012
Factors determining the effectiveness of oral ciclosporin in the treatment of severe childhood atopic dermatitisDavid R Beaumont, Peter D Arkwright
Pageof 17